Clover Health Investments, Corp.
CLOV
$3.60
$0.010.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 53.17% | 1.41% | |||
| Total Other Revenue | 172.48% | -89.03% | |||
| Total Revenue | 53.61% | -1.64% | |||
| Cost of Revenue | 42.60% | -2.36% | |||
| Gross Profit | 114.99% | 2.53% | |||
| SG&A Expenses | 6.97% | 26.72% | |||
| Depreciation & Amortization | 22.62% | 3.45% | |||
| Other Operating Expenses | -- | 100.00% | |||
| Total Operating Expenses | 34.42% | 3.23% | |||
| Operating Income | 155.42% | -102.32% | |||
| Income Before Tax | 155.42% | -102.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 155.42% | -102.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 155.42% | -102.32% | |||
| EBIT | 155.42% | -102.32% | |||
| EBITDA | 156.95% | -103.99% | |||
| EPS Basic | 154.82% | -100.84% | |||
| Normalized Basic EPS | 154.87% | -100.67% | |||
| EPS Diluted | 152.41% | -100.84% | |||
| Normalized Diluted EPS | 154.87% | -100.67% | |||
| Average Basic Shares Outstanding | 0.96% | 0.88% | |||
| Average Diluted Shares Outstanding | 0.96% | 0.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||